VEGI Human
Human Vascular Endothelial Growth Inhibitor Recombinant
人腫瘤壞死因子配體相關(guān)分子-1A
Catalog No. CYT-517

Synonyms:
Tumor necrosis factor ligand superfamily member 15, TNFSF-15, TNFSF15, TNF ligand-related molecule 1, VEGI, TL-1, TL1, TL1A, VEGI192A, VEGI-192, MGC129934, MGC129935.

Introduction:
TNFSF15 is a cytokine that belongs to the tumor necrosis factor （TNF） ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of TNFSF15 is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. TNFSF15 is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. An additional isoform encoded by an alternatively spliced transcript variant has been reported but the sequence of this transcript has not been determined.

Description:
TNFSF15 Human Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain containing 192 amino acids and having a molecular mass of 21.8 kDa.
The TNFSF15 is purified by proprietary chromatographic techniques.

Source:
Escherichia Coli.

Physical Appearance:
Sterile Filtered White lyophilized （freeze-dried） powder.

Formulation:
The TNFSF15 was lyophilized from a concentrated （1 mg/ml） solution containing 0.5M NaCl and 50mM Tris-HCl pH-7.5.

Solubility:
It is recommended to reconstitute the lyophilized TNFSF15 in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.

Stability:
TNFSF15 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution VEGI should be stored at 4°C between 2-7 days and for future use below -18°C.
For long term storage it is recommended to add a carrier protein （0.1% HSA or BSA）.
Please prevent freeze-thaw cycles.

Purity:
Greater than 95.0% as determined by:
（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE.

Amino acid sequence:
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Leu-Thr-Lys.

Biological Activity:
The ED₅₀ as determined by the dose-dependant inhibition of the proliferation of HUVEC （Human Umbilical Vein Endothelial Cells） is less then 5μg/ml.

Usage:
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

相關(guān)產(chǎn)品：

TNFR2 重組人腫瘤壞死因子受體2 CYT-674 Recombinant Human Tumor Necrosis Factor Receptor Type 2
TSLP 重組人淋巴細(xì)胞生成素 CYT-572 Recombinant Human Thymic Stromal Lymphopoietin
TPO 重組人血小板生成素 CYT-302 Recombinant Human Thrombopoietin
TPO CHO 重組人血小板生成素 CYT-462 Recombinant Human Thrombopoietin, CHO
mTPO 重組小鼠血小板生成素 CYT-346 Recombinant Mouse Thrombopoietin
TRAIL 人腫瘤壞死因子相關(guān)凋亡誘導(dǎo)因子配體 CYT-443 Recombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2L
TRAIL （114-281 a.a.） 人腫瘤壞死因子相關(guān)凋亡誘導(dǎo)因子配體 CYT-546 Recombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2L （114-281）
Vaspin 重組人內(nèi)臟脂肪特異性絲氨酸蛋白酶抑制劑 CYT-459 Recombinant Human Vaspin
VEGF 重組人血管內(nèi)皮生長(zhǎng)因子 CYT-241 Recombinant Human Vascular Endothelial Growth Factor
VEGF His 重組人血管內(nèi)皮生長(zhǎng)因子 His CYT-496 Recombinant Human Vascular Endothelial Growth Factor His Tag
VEGF CHO 重組人血管內(nèi)皮生長(zhǎng)因子 CHO CYT-260 Recombinant Human Vascular Endothelial Growth Factor, CHO
VEGF Sf9 重組人血管內(nèi)皮生長(zhǎng)因子 Sf9 CYT-225 Recombinant Human Vascular Endothelial Growth Factor, Sf9
VEGF Yeast 重組人血管內(nèi)皮生長(zhǎng)因子 Yeast CYT-577 Recombinant Human Vascular Endothelial Growth Factor, Yeast
VEGF （121a.a.） 重組人血管內(nèi)皮生長(zhǎng)因子 （121a.a.） CYT-343 Recombinant Human Vascular Endothelial Growth Factor （121）
VEGF （121a.a.） Sf9 重組人血管內(nèi)皮生長(zhǎng)因子 （121a.a.） Sf9 CYT-200 Recombinant Human Vascular Endothelial Growth Factor （121）, Sf9
VEGF （121a.a.） His 重組人血管內(nèi)皮生長(zhǎng)因子 （121a.a.） His CYT-619 Recombinant Human Vascular Endothelial Growth Factor （121） His Tag
rmVEGF 重組小鼠血管內(nèi)皮生長(zhǎng)因子 CYT-336 Recombinant Mouse Vascular Endothelial Growth Factor
mVEGF Sf9 重組小鼠血管內(nèi)皮生長(zhǎng)因子 Sf9 CYT-226 Recombinant Mouse Vascular Endothelial Growth Factor-Sf9
rmVEGF （121a.a.） 重組小鼠血管內(nèi)皮生長(zhǎng)因子 （121a.a.） CYT-574 Recombinant Mouse Vascular Endothelial Growth Factor （121）
rVEGF 重組大鼠血管內(nèi)皮生長(zhǎng)因子 CYT-392 Recombinant Rat Vascular Endothelial Growth Factor
mVEGF His 重組小鼠血管內(nèi)皮生長(zhǎng)因子 His CYT-680 Recombinant Mouse Vascular Endothelial Growth Factor His Tag
VEGFB 重組人血管內(nèi)皮生長(zhǎng)因子B CYT-628 Recombinant Human Vascular Endothelial Growth Factor B
VEGF-C 重組人血管內(nèi)皮生長(zhǎng)因子相關(guān)蛋白 CYT-527 Recombinant Human Vascular Endothelial Growth Factor Related Protein
rVEGF-C 重組大鼠血管內(nèi)皮生長(zhǎng)因子相關(guān)蛋白 CYT-262 Recombinant Rat Vascular Endothelial Growth Factor Related Protein
rVEGF-C （152a.a.） 重組大鼠血管內(nèi)皮生長(zhǎng)因子C（152a.a.） CYT-284 Recombinant Rat Vascular Endothelial Growth Factor-C （152）
VEGF-E （Orf Virus） 重組血管內(nèi)皮生長(zhǎng)因子E（Orf Virus） CYT-263 Recombinant Vascular Endothelial Growth Factor-E （Orf Virus）
VEGI/TL1A 人腫瘤壞死因子配體相關(guān)分子-1A CYT-517 Recombinant Human Tumor necrosis factor ligand superfamily member 15
Visfatin 重組人內(nèi)脂素 CYT-318 Recombinant Human Visfatin
Visfatin His 重組人內(nèi)脂素 His CYT-563 Recombinant Human Visfatin, His Tag
mVisfatin 重組小鼠內(nèi)脂素 CYT-447 Recombinant Mouse Visfatin